小分子NEK2干扰RNA对肺癌细胞耐药的研究(4)
| 第1页 |
参见附件。
[6] Kallianos A，Rapti A，Zarogoulidis P，et al. Therapeutic procedure in small cell lung cancer [J]. J Thorac Dis，2013，5(4)：S420-S424.
[7] 翁汉钦，何小玲.Nek2异常表达的肿瘤学研究进展[J].国际检验医学杂志，2008，2(3)：230-232，235.
[8] Lee J，Gollahon L. Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triplenegative breast cancer cells [J]. Int J Oncol，2013，42(3)：839-847.
[9] Shaukat Z，Wong HW，Nicolson S，et al. A screen for selective killing of cells with chromosomal instability induced by a spindle checkpoint defect [J]. PLoS One，2012，7(10)：e47447.
[10] Fry AM，O'Regan L，Sabir SR，et al. Cell cycle regulation by the NEK family of protein kinases [J]. J Cell Sci，2012，125(Pt 19)：4423-4433.
[11] Prigent C，Glover DM，Giet R. Drosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failure [J]. Exp Cell Res，2005，303(1)：1-13.
[12] Spallarossa P，Altieri P，Aloi C，et al. Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 [J]. Am J Physiol Heart Circ Physiol，2009，297(6)：2169-2181.
(收稿日期：2013-09-06 本文编辑：李继翔)
您现在查看是摘要介绍页，详见PDF附件。